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Axillary to saphenous vein bypass for treatment of
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dialysis
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Objective: Venous hypertension due to subclavian or innominate vein stenosis coexisting with a functioning arteriovenous
access in the ipsilateral arm is a complex problem in patients undergoing hemodialysis. Therapeutic solutions must
optimally relieve symptoms, permit use of the angioaccess, and carry minimal surgical risk. The purpose of this study was
to evaluate a simple surgical option, bypassing central venous obstruction to the great saphenous vein.
Methods: Eight patients undergoing hemodialysis with severe symptoms and signs of venous hypertension due to
subclavian or innominate vein obstruction and ipsilateral arteriovenous fistula or graft underwent axillosaphenous bypass
via a subcutaneous 8-mm polytetrafluoroethylene bridge graft.
Results: No intraoperative or immediate postoperative morbidity was observed. Early and 6-month patency rates were
100% and 87.5%, respectively. All patients reported improvement of symptoms, and the angioaccess was usable in all
cases. Average follow-up was 21.5 months. One patient had a relapse at 5 months, which necessitated revision of the
graft–saphenous vein anastomosis.
Conclusion: Bypassing a central vein occlusion to the saphenous vein relieves symptoms of venous hypertension and
prolongs use of the hemodialysis angioaccess. ( J Vasc Surg 2004;40:640-3.)Stenosis or obstruction of the superior vena cava or more
frequently its major tributaries is common in patients with
end-stage renal failure undergoing maintenance hemodialy-
sis.1 The situation causes no symptoms unless coexistence of
an arteriovenous fistula or arteriovenous graft in the ipsilateral
arm causes severe venous hypertension.1,2 Mild edema may be
tolerated by the patient; in contrast, severe incapacitating arm
swelling, ulceration, high-pressure venous return during he-
modialysis, or persistent bleeding from cannulation points
require some therapeutic intervention. Abolition of the arte-
riovenous communication seems the simplest option3; never-
theless, it does not provide a solution to the underlying
disorder, and furthermore it deprives the patient of a site of
angioaccess. Venous reconstruction4 or bypass to the internal
jugular vein, the external jugular vein, or the right atrium have
been described as alternative options of surgical manage-
ment.2,5-11
We describe a new approach for bypassing the occluded
central vein via a prosthetic graft to the saphenous vein.
This approach was used in 8 patients with a functioning
angioaccess in the ipsilateral arm.
MATERIAL AND METHODS
Eight patients (4 men, 4 women) with a median age of
61 years (range, 47-63 years) had severe arm swelling and a
functioning arteriovenous angioaccess. All patients had a
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doi:10.1016/j.jvs.2004.07.009640history of ipsilateral subclavian vein catheter insertion, to be
used as a temporary hemodialysis access. No accurate data
concerning the number of catheter insertions, duration of
use as an angioaccess, or infections were available. Previous
deep venous thrombosis was ruled out by history; iliofem-
oral vein patency was confirmed at meticulous clinical and
Doppler ultrasound examination. Clinical presentation and
location of obstruction are presented in Table I.
Perioperative management. A single intravenous
dose of 400 mg of teicoplanin was given preoperatively.
Before preparation of the operative field a pneumatic tour-
niquet was applied to the ipsilateral arm to restrict extreme
blood loss by inflation and occlusion of the arteriovenous
communication in case of bleeding. Postoperatively no
restriction in patient motility was advocated, and as a rule
no anticoagulant agents or antiplatelet drugs were admin-
istered; no use of elastic stockings was recommended.
Surgical technique. The procedure was performed
with the patient under local anesthesia in 7 cases. Systemic
heparinization was used in 3 patients. The axillary vein was
accessed through a 5-cm to 6-cm subclavicular incision in 6
patients, and through axillary incision in 2 patients. The
long saphenous vein was dissected at the saphenofemoral
junction and 5 to 6 cm distally. An 8-mm polytetrafluoro-
ethylene (PTFE) graft was inserted subcutaneously to
bridge the 2 veins. The graft was standard wall in 3 cases
and thin wall externally supported in 5 cases. A 10-mm
venotomy was made in the axillary vein, and a 20-mm
venotomy in the saphenous vein. The graft was anasto-
mosed end-to-side to the veins. The great saphenous vein
was not ligated distally (Fig).
Graft patency during follow-up was controlled by mur-
mur auscultation and Doppler ultrasound scanning every 3
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formed.
RESULTS
No blood transfusion was required. The postoperative
period was uneventful in all patients. The access was used
on the first postoperative day. No leg edema or varicosities
were recorded during follow-up. Four patients reported
immediate improvement with regard to a sensation of
heaviness. In all patients arm stiffness and swelling began to
subside during the first postoperative day; within 7 to 10
days the affected arm had less than 4 cm difference in
perimeter compared with the contralateral arm, and pa-
tients were absolutely symptom-free. Ipsilateral hand hy-
perpigmentation remained in 2 patients; however, 1 of
those patients experienced healing of an accompanying
ulcer. Follow-up ranged from 7 to 56 months. One graft
failed 5 months after insertion; patency of this graft was
restored with thrombectomy and revision. Infection of an
inguinal wound was observed in this patient, which re-
solved after drainage. Bridge graft and access patency data
are presented in Table II.
DISCUSSION
Marked edema has been reported in 11% of patients
with a history of subclavian vein catheter after A-V fistula
creation.1 Functional disability of the involved extremity
remains the major side effect, occurring in approximately
75% of patients.5 Treatment options include closure of the
fistula, percutaneous transluminal angioplasty, and bypass
of the occluded vein segment. Ligation of the access is a
simple and effective method for correcting symptomatic
stenosis or occlusion of a central vein, and is probably the
most frequently performed procedure.1-3 However, such
treatment not only destroys the functional A-V access in a
patient critically dependent on hemodialysis, but renders
the limb unsuitable for future use as an angioaccess site.
Percutaneous transluminal angioplasty is widely performed
as a less invasive procedure, with satisfactory short-term
results, but high reccurence rates with balloon dilation
alone have led to the widespread adoption of stenting.12
In a series comparing surgical and transcutaneous proce-
dures, primary symptomatic relief at 1 year was achieved
in 88% of patients in the surgical group versus 36% in the
angioplasty group. One-year and 2-year success rates
with repeated angioplasty were 86% and 66%, respective-
ly.13 Complication rates of stent therapy have ranged
from 0% to 50%.12-14 Direct repair of the stenotic vein
seems to be the most reasonable approach, but requires a
major surgical procedure. The results of this approach do
not seem to differ markedly from those of other proce-
dures.4
Surgical bypass of the thrombosed area enables conser-
vation of the fistula and preserves other areas for future
access sites9; it is currently considered the gold standard,12
given satisfactory long-term patency and low perioperative
morbidity rates. A spiral vein15 or PTFE10 graft has been
used to bridge the axillary, subclavian, or innominate veinwith the right atrium. Nevertheless, there are concerns
about the magnitude of such a procedure in a patient
population at high risk. Ipsilateral, or rarely contralateral,
internal jugular vein has most commonly been used, either
as a conduit 6,7,16 or as a site of anastomosis of the bypass-
ing graft from the axillary or the distal subclavian
vein.2,5,8,16 Although internal jugular vein is a suitable
option for bypass, because of its vicinity to the axillary vein,
it is associated with 2 main disadvantages. First, if the vein
is used as a conduit, it must be ligated and transected,
depriving the patient of a site for possible future catheter
insertion. Furthermore, the procedure is feasible only if the
contralateral internal jugular vein is normal. Second, con-
trast agent–enhanced studies rarely permit precise localiza-
tion of the obstruction or accurate estimation of its length,
because abundant collateral vessels often obscure the re-
gion of obstruction, and frequently the vascular defect
extends farther from the previous catheter insertion point.4
Thus, if the obstruction happens to be located or extends
proximally to the jugular-subclavian junction, this kind of
bypass is useless. This problem is also relevant to use of
external jugular vein9,11 as a receptor site of the bypass.
Although bypass to the saphenous vein is free of all of these
Schematic representation of bridge graft route from axillary vein
(subclavian region, n  6; axilla, n  2) to long saphenous vein.
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limited, focused on management of superior vena cava
syndrome.17,18
A major concern is the patency of such a long veno-
venous graft. Many factors contribute to poor patency rates
of conduits used in vein reconstruction,16 including inad-
equate flow, material thrombogenicity, and graft collaps-
ibility. Autologous vein grafts (long saphenous vein either
reversed or sewn in a spiral pattern) have been used for vein
reconstruction or bypass, because of minimal material
thrombogenicity, but the technique depends absolutely on
the availability and quality of the saphenous vein. More-
over, vein conduits are collapsible, and in the case of
axillary-saphenous bypass their length is inadequate to
bridge the gap between the 2 vessels, and their occlusion
rate is high.19 PTFE conduits are less thrombogenic than
other synthetic grafts, and less collapsible, especially in the
externally supported version, and thus are widely used.
A well-established treatment of the low velocity prob-
lem in vein reconstructive surgery is creation of an A-V
fistula distal to the reconstruction.20 This is a preexisting
advantage in these patients, and must be considered as the
main factor maintaining graft patency.8 In our first patient
the graft became thrombosed after deterioration of the A-V
fistula; that was the reason for no symptom relapse. The
Table I. Clinical data
Patient Symptoms at presentation
1 Arm, face, and breast swelling; ectropion;
thrombosis of jugulo-jugular graft
s-s
2 Arm, breast edema; difficulty cannulating fistula s-s
3 Arm edema e-s
4 Arm edema, hand ulcer, hyperpigmentation,
bleeding cannulation sites
s-s
5 Arm edema; difficulty cannulating fistula A-V
6 Arm edema, hand ulcer, hyperpigmentation s-s
7 Arm edema, prolonged bleeding time, breast
edema, epiphlebon, ectropion
A-V
8 Arm edema, impossible cannulation s-s
s-s, Side-to-side; e-s, end-to-side; A-V, arteriovenous.
Table II. Results
Patient
Follow-up
(mo)
Bridge graft
patency
(mo)
Access patency
(mo)
1 56 56 54 Bridg
no
2 18 18 18 Death
3 36 36 36 Lost t
4 20 20 20 Graft
5 17 17 17 Graft
6 8 8 8 Graft
7 7 5 7 Throm
pos
gra
8 10 10 10 Graftsuccess of surgery in this group of patients should be judged
on the duration of A-V fistula function.4 In 1999 Schindler
et al12 published a meta-analysis of 5 series with a total
number of 53 patients who had undergone surgical bypass
to treat superior vena cava syndrome since 1990. Most of
those patients received a PTFE graft; spiral vein grafts were
used less often. Primary patency rates ranging from 67% to
100%, secondary patency rates of up to 100%, and 5-year
patency rate of 86% were reported.12 In patients undergo-
ing hemodialysis after different surgical procedures, Bhatia
et al20 reported 100% initial patency, 92% 6-month pa-
tency, and 83% 1-year patency. In the present study the
initial patency was 100%, primary 6-month patency was
87.5%, and secondary 6-month patency was 100%.
Satisfactory results have been reported with internal
jugular vein–superior vena cava transposition, but multiple
incisions are necessary, most probably along with resection
of the clavicle. Internal jugular vein is sacrificed, therefore
precluding its use for temporary access, hemodynamic
monitoring, or even outflow for A-V fistulas. The proce-
dure is contraindicated if there is occlusion of the contralat-
eral internal jugular vein or innominate vein. Unless the
clavicle is resected to enable complete mobilization of the
internal jugular vein down to the innominate vein, the
internal jugular vein kinks and may be functionally ob-
pe of access
Access construction to
bypass (mo)
Location of central
vein occlusion
fistula 18 Left innominate
fistula 5 Right innominate
fistula No data Left subclavian
fistula 8 Right subclavian
ft loop, forearm 10 Left subclavian
fistula 7 Right subclavian
ft mid-humer 12 Left innominate
fistula 7 Right subclavian
Clinical outcome
t thrombosed owing to diminished arteriovenous fistula patency;
e of any symptom or sign
unrelated reason; bridge graft and access patent
ow-up
unctioning
unctioning
unctioning
omy and dilation of graft-saphenous anastomosis in
ative month 5; partial resolution of edema, access in use, bridge
ent
unctioningTy
A-V
A-V
A-V
A-V
gra
A-V
gra
A-Ve graf
relaps
from
o foll
still f
still f
still f
bect
toper
ft pat
still f
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superior vena cava.4 The recently reported technique of
decompression of A-V graft to the ipsilateral femoral vein21
offers a solution only to the excess pressure problem, leav-
ing the arm unsuitable for further use in case of occlusion of
the decompressed graft. Graft dissection in an arm with
venous hypertension is not an attractive option, and the
method is of questionable applicability in cases of A-V
fistula. Use of femoral vein is also a less safe alternative in a
complicated case. An axillosaphenous bypass is a much
more simple procedure, accomplished easily with the pa-
tient under local anesthesia, and carries substantially less
risk, with comparable results.
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